Market Cap 42.25B
Revenue (ttm) 5.44B
Net Income (ttm) 4.17B
EPS (ttm) N/A
PE Ratio 27.66
Forward PE 29.59
Profit Margin 76.75%
Debt to Equity Ratio 0.06
Volume 2,865,718
Avg Vol 4,560,214
Day's Range N/A - N/A
Shares Out 587.87M
Stochastic %K 76%
Beta 1.15
Analysts Sell
Price Target $79.08

Latest News on EW

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead

Mar 22, 2025, 11:51 PM EDT - 11 days ago

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead


Edwards Lifesciences Reports Fourth Quarter Results

Feb 11, 2025, 4:15 PM EST - 7 weeks ago

Edwards Lifesciences Reports Fourth Quarter Results


4 Strong Stock Charts For 2025 (Technical Analysis)

Dec 30, 2024, 12:00 PM EST - 3 months ago

4 Strong Stock Charts For 2025 (Technical Analysis)

DRI JBL KR